Lucira Health, a California based company, has just received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA) for its fully-at-home COVID-19 diagnostic test. It will be available on a national level in Spring of 2021 for people over 14, delivering results in 30 minutes. The FDA has also authorized the 94% effective Lucira test-kit in point-of-care centers as well. The challenge faced with the fully-at-home test kit is that the infected may or may not choose to report their results to their provider.
Learn more here.
More on: News Regulatory